跳至主要内容
临床试验/NCT04996615
NCT04996615招募中不适用

Peking University People's Hospital Breast Center

Peking University People's Hospital2 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
2
主要终点
screening yield

研究概览

简要总结

Use Convolutional Neural Networks Analysis for Classification of Contrast-enhancing Lesions at Multiparametric Breast MRI. Build an abbreviated protocal, and investigate whether an abbreviated protocol was suitable for breast magnetic resonance imaging screening for breast cancer in high-risk Chinese women, which can shorten the examination time and avoid enhanced imaging while ensuring the accuracy of the diagnosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Patients undergoing full sequence BMRI examination
  • Written informed consent and complete the clinical data questionnaire
  • Through the follow-up database, at least 6 months of follow-up results can be obtained to determine whether the diagnosis result is negative/benign/malignant; for patients who need pathological biopsy, the pathological biopsy results shall prevail to determine the lesion benign/malignant.

排除标准

  • The breast had received radiotherapy, chemotherapy, biology and other treatments before BMRI.
  • Signs or symptoms of breast disease
  • There are contraindications for breast-enhanced MRI examinations such as allergy to contrast agents.
  • Patients during lactation or pregnancy

结局指标

主要结局

screening yield

时间窗: 5 years

compare the rates of detection of breast cancers in the screening of high-risk populations between the Breast MRI full sequence, contrast-enhanced and non-contrast-enhanced sequence.

次要结局

  • The accuracy of radiologists and deep learning models(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shu Wang

Director of Breast Center

Peking University People's Hospital

研究点 (2)

Loading locations...

相似试验